Abstract
The outcome of natural infections with pathogenic mycobacteria can range from early asymptomatic clearance through latent infection to clinical disease. Different host and pathogen-specific factors have been implicated in determining the outcome of these infections; however, it is clear that the interaction of mycobacteria with the innate and acquired components of the immune system plays a central role. Specifically, the recognition of mycobacterial components by innate immune cells through different pathogen recognition receptors (PPRs) induces a cytokine response that can promote early control of the infection. In fact, in the majority of individuals that come into contact with mycobacteria, this response is enough to control the infection. Among PRRs, Toll-like receptors (TLRs), Nucleotide Oligomerization Domain (NOD)-like receptors, and C-type lectins have all been implicated in recognition of mycobacteria and in the initiation of the cytokine response. Defining the mechanisms by which distinct mycobacterial components and their receptors stimulate the immune response is an area of intense research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stumhofer J, Tait E, Quinn Wr, Hosken N, Spudy B, Goenka R et al (2010) A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol 11:1119–1126
Collison L, Workman C, Kuo T, Boyd K, Wang Y, Vignali K et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450:566–569
Cooper AM (2009) Cell mediated immune responses in tuberculosis. Annu Rev Immunol 27:393–422
Cooper A (2009) T cells in mycobacterial infection and disease. Curr Opin Immunol 21:378–384
Cooper AM, Khader SA (2008) The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 226:191–204
Wolf A, Desvignes L, Linas B, Banaiee N, Tamura T, Takatsu K et al (2008) Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 205:105–115
Reiley W, Calayag M, Wittmer S, Huntington J, Pearl J, Fountain J et al (2008) ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in mediastinal lymph nodes. Proc Natl Acad Sci U S A 105:10961–10966
Gallegos A, Pamer E, Glickman M (2008) Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med 205:2359–2368
Wolf AJ, Linas B, Trevejo-Nunez GJ, Kincaid E, Tamura T, Takatsu K et al (2007) Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 179:2509–2519
Cooper A, Solache A, Khader S (2007) Interleukin-12 and tuberculosis: an old story revisited. Curr Opin Immunol 19:441–447
Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J et al (2006) Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 18:347–361
Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, Orme IM (2002) Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 168:1322–1327
Khader S, Pearl J, Sakamoto K, Gilmartin L, Bell G, Jelley-Gibbs D et al (2005) IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-g responses if IL-12p70 is available. J Immunol 175:788–795
Torrado E, Cooper AM (2010) IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev 21:455–462
Wozniak T, Ryan A, Britton W (2006) Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J Immunol 177:8684–8692
Khader S, Bell G, Pearl J, Fountain J, Rangel-Moreno J, Cilley G et al (2007) IL-23 and IL-17 in establishment of protective pulmonary CD4+ T cell responses upon vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8:369–377
Pflanz S, Timans J, Cheung J, Rosales R, Kanzler H, Gilbert J et al (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16:779–790
Pearl JE, Shabaana AK, Solache A, Gilmartin L, Ghilardi N, deSauvage F et al (2004) IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol 173:7490–7496
Holscher C, Holscher A, Ruckerl D, Yoshimoto T, Yoshida H, Mak T et al (2005) The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174:3534–3544
Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H et al (2003) The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645–655
Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, Takeda A et al (2003) WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19:641–644
Batten M, Ghilardi N (2007) The biology and therapeutic potential of interleukin 27. J Mol Med 85:661–677
Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S et al (2007) Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8:1372–1379
Stumhofer J, Silver J, Laurence A, Porrett P, Harris T, Turka L et al (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8:1363–1371
Cruz A, Fraga A, Fountain J, Rangel-Moreno J, Torrado E, Saraiva M et al (2010) Pathological role of Interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med 207:1609–1616
Desvignes L, Ernst JD (2009) Interferon-g-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31:974–985
Cruz A, Khader S, Torrado E, Fraga A, Pearl J, Pedrosa J et al (2006) Cutting edge: IFN-g regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 177:1416–1420
Wieland CW, van der Windt GJ, Florquin S, McKenzie AN, van der Poll T (2009) ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis. Microbes Infect 11:524–530
Scanga C, Bafica A, Feng C, Cheever A, Hieny S, Sher A (2004) MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun 72:2400–2404
Fremond C, Yeremeev V, Nicolle D, Jacobs M, Quesniaux V, Fatal RB (2004) Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Investig 114:1790–1799
Mayer-Barber K, Barber D, Shenderov K, White S, Wilson MS, Cheever A et al (2010) Cutting Edge: Caspase-1 independent IL-1b production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 184:3326–3330
Mayer-Barber KD, Andrade BB, Barber DL, Hieny S, Feng CG, Caspar P et al (2011) Innate and adaptive interferons suppress IL-1a and IL-1b production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35:1023–1034
Mariathasan S, Monack DM (2007) Inflammasome adaptors and sensors: Intracellular regulators of infection and inflammation. Nat Rev Immunol 7:31–40
Mishra BB, Moura-Alves P, Sonawane A, Hacohen N, Griffiths G, Moita LF et al (2010) Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 12:1046–1063
McElvania Tekippe E, Allen IC, Hulseberg PD, Sullivan JT, McCann JR, Sandor M et al (2010) Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1. PLoS ONE 5:e12320
Walter K, Holscher C, Tschopp J, Ehlers S (2010) NALP3 is not necessary for early protection against experimental tuberculosis. Immunobiology 215:804–811
Koo IC, Wang C, Raghavan S, Morisaki JH, Cox JS, Brown EJ (2008) ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cell Microbiol 10:1866–1878
Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M, Boekhout T et al (2012) Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1b via a noncanonical caspase-8 inflammasome. Nat Immunol 13:246–254
Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550
van de Veerdonk F, Teirlinck A, Kleinnijenhui J, Jan Kullberg B, van Creval R, van der Meer J et al (2010) Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J Leukoc Biol 88:227–232
Aujla S, Dubin P, Kolls J (2007) Th17 cells and mucosal host defense. Semin Immunol 19:377–382
Hurgin V, Novick D, Werman A, Dinarello CA, Rubinstein M (2007) Antiviral and immunoregulatory activities of IFN-g depend on constitutively expressed IL-1a. Proc Natl Acad Sci U S A 104:5044–5049
Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Whittle HC (1998) A.V.S.H. Assessment of the Interleukin-1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuberc Lung Dis 79:83–89
Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G et al (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1b on tuberculosis. J Exp Med 189:1863–1874
Okamura H, Tsutsui H, Komatsu T, Yatsudo M, Hakura A, Tanimoto T et al (1995) Cloning of a new cytokine that induces IFN-g production by T cells. Nature 378:88–91
Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, Akira S (1999) Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun 67:2585–2589
Kinjo Y, Kawakami K, Uezu K, Yara S, Miyagi K, Koguchi Y et al (2002) Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis. J Immunol 169:323–329
Schneider BE, Korbel D, Hagens K, Koch M, Raupach B, Enders J et al (2010) A role for IL-18 in protective immunity against Mycobacterium tuberculosis. Eur J Immunol 40:396–405
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Eng J Med 345:1098–1104
Roach D, Bean A, Demangel C, France M, Briscoe H, Britton W (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620–4627
Saunders B, Tran S, Ruuls S, Sedgwick J, Briscoe H, Britton W (2005) Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol 174:4852–4859
Flórido M, Appelberg R (2007) Characterization of the deregulated immune activation occurring at late stages of mycobacterial infection in TNF-deficient mice. J Immunol 179:7702–7708
Tobin DM, Vary JC Jr, Ray JP, Walsh GS, Dunstan SJ, Bang ND et al (2010) The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140:717–730
Torrado E, Cooper AM (2011) What do we really know about how CD4 T cells control Mycobacterium tuberculosis? PLoS Pathog 7:e1002196
Gallegos AM, van Heijst JWJ, Samstein M, Su X, Pamer EG, Glickman MS (2011) A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo. PLoS Pathog 7:e1002052
Bold TD, Banaei N, Wolf AJ, Ernst JD (2011) Suboptimal activation of antigen-specific CD4+Â effector cells enables persistence of M. tuberculosis in vivo. PLoS Pathog 7:e1002063
Egen JG, Rothfuchs AG, Feng CG, Horwitz MA, Sher A, Germain RN (2011) Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34:807–819
Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178:2243–2247
Nandi B, Behar SM (2011) Regulation of neutrophils by interferon-g limits lung inflammation during tuberculosis infection. J Exp Med 208:2251–2262
Cooper AM, Adams LB, Dalton DK, Appelberg R, Ehlers S (2002) IFN-g and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol 10:221–226
Florido M, Pearl J, Solache A, Borges M, Haynes L, Cooper A et al (2005) Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection. Infect Immun 73:3577–3586
Antonelli LR, Gigliotti Rothfuchs A, Goncalves R, Roffe E, Cheever AW, Bafica A et al (2010) Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest 120:1674–1682
Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM et al (2001) Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci U S A 98:5752–5757
Stanley SA, Johndrow JE, Manzanillo P, Cox JS (2007) The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J Immunol 178:3143–3152
O’Connell RM, Vaidya SA, Perry AK, Saha SK, Dempsey PW, Cheng G (2005) Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1. J Immunol 174:1602–1607
Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T et al (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973–977
Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P et al (2001) Requirement of Interleukin-17 receptor signalling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recriutment, and host defense. J Exp Med 194:519–527
Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR et al (2001) Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Crit Care Med 25:335–340
Happel K, Dubin P, Zheng M, Ghilardi N, Lockhart C, Quinton L et al (2005) Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202:761–769
Hamada S, Umemura M, Shiono T, Tanaka K, Yahagi A, Begum MD et al (2008) IL-17A produced by gammadelta T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 181:3456–3463
Okamoto Yoshida Y, Umemura M, Yahagi A, O’Brien R, Ikuta K, Kishihara K et al (2010) Essential role of IL-17A in the formation of a mycobacterial Infection-induced granuloma in the lung. J Immunol 184(8):4414–4422
Blomgran R, Desvignes L, Briken V, Ernst JD (2012) Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe 11:81–90
Seiler P, Aichele P, Bandermann S, Hauser A, Lu B, Gerard N et al (2003) Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol 33:2676–2686
Silva MT (2010) When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J Leukoc Biol 87:93–106
Khader SA, Guglani L, Rangel-Moreno J, Gopal R, Fallert Junecko BA, Fountain JJ et al (2011) IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol 187:5402–5407
Wilson MS, Feng CG, Barber DL, Yarovinsky F, Cheever AW, Sher A et al (2010) Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 184:4378–4390
Liang S, Tan X, Luxenberg D, Karim R, Dunussi-Joannopoulos K, Collins M et al (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271–2279
Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, Black G et al (2008) Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180:1962–1970
Turner J, Gonzalez-Juarrero M, Ellis D, Basaraba R, Kipnis A, Orme I et al (2002) In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 169:6343–6351
Beamer G, Flaherty D, Assogba B, Stromberg P, Gonzalez-Juarrero M, de Waal Malefyt R et al (2008) Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol 181:5545–5550
O’Leary S, O’Sullivan M, Keane J (2010) IL-10 blocks phagosome maturation in Mycobacterium tuberculosis-infected human macrophages. Am J Respir Cell Mol Biol (epub ahead of print)
Redford P, Boonstra A, Read S, Pitt J, Graham C, Stavropoulos E et al (2010) Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol 40(8):2200–2210
Rook GA, Hernandez-Pando R, Dheda K, Teng Seah G (2004) IL-4 in tuberculosis: implications for vaccine design. Trends Immunol 25:483–488
Potian JA, Rafi W, Bhatt K, McBride A, Gause WC, Salgame P (2011) Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J Exp Med 208:1863–1874
El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M et al (2008) Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 9:1399–1406
Schreiber T, Ehlers S, Heitmann L, Rausch A, Mages J, Murray PJ et al (2009) Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol 183:1301–1312
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Torrado, E., Cooper, A.M. (2013). Cytokines in the Balance of Protection and Pathology During Mycobacterial Infections. In: Divangahi, M. (eds) The New Paradigm of Immunity to Tuberculosis. Advances in Experimental Medicine and Biology, vol 783. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6111-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6111-1_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6110-4
Online ISBN: 978-1-4614-6111-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)